Advisor Resource Council’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$490K Buy
408
+28
+7% +$28.6K 0.14% 148
2026
Q1
$350K Buy
380
+8
+2% +$8.11K 0.11% 159
2025
Q4
$388K Buy
+372
New +$356K 0.14% 160
2025
Q2
Sell
-1,514
Closed -$1.08M 403
2025
Q1
$1.08M Buy
+1,514
New +$1.26M 0.09% 234
2024
Q4
Sell
-998
Closed -$884K 181
2024
Q3
$884K Buy
+998
New +$897K 0.4% 58
2024
Q2
Sell
-910
Closed -$530K 152
2024
Q1
$530K Sell
910
-1,830
-67% -$1.3M 0.22% 105
2023
Q4
$1.6M Buy
+2,740
New +$1.6M 0.19% 131
2022
Q3
Sell
-1,254
Closed -$406K 338
2022
Q2
$406K Buy
+1,254
New +$376K 0.04% 316
2022
Q1
Sell
-1,178
Closed -$326K 388
2021
Q4
$326K Buy
+1,178
New +$299K 0.03% 415
2021
Q3
Sell
-1,073
Closed -$246K 353
2021
Q2
$246K Buy
+1,073
New +$216K 0.03% 432

Other funds holding LLY

Advisor Resource Council's LLY Position: Q2 2026 in Review

Advisor Resource Council increased its Eli Lilly (LLY) stake by 7.4% in Q2 2026, buying an estimated $28.6K and bringing the position to 408 shares worth $490K. The position accounts for 0.14% of the portfolio, ranked #148.

Advisor Resource Council first reported a position in LLY in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.6M in Q4 2023. 4,599 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Advisor Resource Council held 408 shares of Eli Lilly worth $490K as of Q2 2026.
  • Advisor Resource Council bought 28 Eli Lilly shares in Q2 2026, an estimated $28.6K.
  • Eli Lilly made up 0.14% of Advisor Resource Council's portfolio in Q2 2026, its #148 holding.
  • Advisor Resource Council first reported a position in Eli Lilly in Q2 2021 and has held it in 10 quarters since.
  • Advisor Resource Council's Eli Lilly position peaked at $1.6M in Q4 2023.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advisor Resource Council's 13F filing for Q2 2026, filed 28 Jul 2026.